Moreover, treatment of Vk*MYC mice with antibodies against IL-17, IL-17RA, and IL-5 reduced the aggregation of Th17 cells and eosinophils in the bone marrow, which in turn prevented the MM progression (167). Here, IL17A is linked to Miyoshi myopathy.